3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Promyelocytic, Acute
4
Leukemia
3
Neuroblastoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrence
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Interventions
Brentuximab Vedotin
13
fludarabine
8
Cyclophosphamide
8
Rituximab
6
ruxolitinib
5
fludarabine phosphate
5
Melphalan
5
Lenalidomide
5
ponatinib
4
Dexamethasone
4
Busulfan
4
Bortezomib
4
nilotinib
3
Whole-Body Irradiation
3
Vincristine
3
Prednisone
3
Mycophenolic Acid
3
Imatinib Mesylate
3
Doxorubicin
3
Bendamustine Hydrochloride
3
Alemtuzumab
3
vosaroxin
2
pomalidomide
2
Tacrolimus
2
Sugars
2
Stem Cell Transplantation
2
Sirolimus
2
Ondansetron
2
Leukapheresis
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Diseases
×
Arsenic Trioxide
×
Clear all
No trials found.